Abstract
A 31-year old woman with type-1 diabetes mellitus was referred to the hospital because of poor blood glucose control. She had been treated with multiple daily insulin injections but her glycohemoglobin was 8.7 % (NGSP value) . She agreed to undergo continuous subcutaneous insulin infusion (CSII) therapy and was admitted to the ward. Continuous glucose monitoring (CGM) was performed using a CGMS Gold® (Medtronic Minimed, USA) which assayed blood glucose at 5 time-points (before and after breakfast and dinner, and at bed time) , in order to adjust the insulin infusion rate for CSII. There was a remarkable improvement in the blood glucose level and fewer hypoglycemic episodes after instituting CSII therapy. CGM was therefore found to be very useful for the adjustment of CSII.
